Trump nominee Hahn unlikely to change much as FDA commissioner

Little is expected to change at the US FDA in terms of CBD or cannabis policy if president Donald Trump’s nominee Stephen Hahn is approved as commissioner, according to sources contacted by CBD-Intel ...

Restricted content. Do you want to read more?